TY - JOUR
T1 - MicroRNA profiles in familial and sporadic medullary thyroid carcinoma
T2 - Preliminary relationships with RET status and outcome
AU - Mian, Caterina
AU - Pennelli, Gianmaria
AU - Fassan, Matteo
AU - Balistreri, Mariangela
AU - Barollo, Susi
AU - Cavedon, Elisabetta
AU - Galuppini, Francesca
AU - Pizzi, Marco
AU - Vianello, Federica
AU - Pelizzo, Maria Rosa
AU - Girelli, Maria Elisa
AU - Rugge, Massimo
AU - Opocher, Giuseppe
PY - 2012/9/1
Y1 - 2012/9/1
N2 - Background: MicroRNAs (miRNAs) are involved in the pathogenesis of human cancers, including medullary thyroid carcinoma (MTC). The aim of this study was to test the hypothesis that different miRNA profiles are related to RET status and prognosis in patients with hereditary MTC (hMTC) and sporadic MTC (sMTC). Methods: We analyzed the expression of nine miRNAs (miR-21, miR-127, miR-154, miR-224, miR-323, miR-370, miR-9*, miR-183, and miR-375) by quantitative real-time-polymerase chain reaction in 34 cases of sMTC, 6 cases of hMTC, and 2 cases of C-cell hyperplasia (CCH). We also analyzed the immunohistochemical expression of PDCD4, an miR-21 gene target. sMTC (n=34) was genotyped for somatic RET and RAS mutations. Disease status was defined on the basis of the concentration of serum calcitonin at the latest follow-up and other parameters as indicated in the results. Results: MTC and CCH were both characterized by a significant overexpression of the whole set of miRNAs (the increase being 4.2-fold for miR-21, 6.7-fold for miR-127, 8.8-fold for miR-154, 6.6-fold for miR-224, 5.8-fold for miR-323, 6.1-fold for miR-370, 13-fold for miR-9*, 6.7-fold for miR-183, and 10.1 for miR-375, p
AB - Background: MicroRNAs (miRNAs) are involved in the pathogenesis of human cancers, including medullary thyroid carcinoma (MTC). The aim of this study was to test the hypothesis that different miRNA profiles are related to RET status and prognosis in patients with hereditary MTC (hMTC) and sporadic MTC (sMTC). Methods: We analyzed the expression of nine miRNAs (miR-21, miR-127, miR-154, miR-224, miR-323, miR-370, miR-9*, miR-183, and miR-375) by quantitative real-time-polymerase chain reaction in 34 cases of sMTC, 6 cases of hMTC, and 2 cases of C-cell hyperplasia (CCH). We also analyzed the immunohistochemical expression of PDCD4, an miR-21 gene target. sMTC (n=34) was genotyped for somatic RET and RAS mutations. Disease status was defined on the basis of the concentration of serum calcitonin at the latest follow-up and other parameters as indicated in the results. Results: MTC and CCH were both characterized by a significant overexpression of the whole set of miRNAs (the increase being 4.2-fold for miR-21, 6.7-fold for miR-127, 8.8-fold for miR-154, 6.6-fold for miR-224, 5.8-fold for miR-323, 6.1-fold for miR-370, 13-fold for miR-9*, 6.7-fold for miR-183, and 10.1 for miR-375, p
UR - http://www.scopus.com/inward/record.url?scp=84865597105&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84865597105&partnerID=8YFLogxK
U2 - 10.1089/thy.2012.0045
DO - 10.1089/thy.2012.0045
M3 - Article
C2 - 22747440
AN - SCOPUS:84865597105
VL - 22
SP - 890
EP - 896
JO - Thyroid
JF - Thyroid
SN - 1050-7256
IS - 9
ER -